Michael E. Prevoznik - 04 Mar 2026 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
SVP & General Counsel
Signature
Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik
Issuer symbol
DGX
Transactions as of
04 Mar 2026
Net transactions value
-$799,682
Form type
4
Filing time
06 Mar 2026, 16:44:30 UTC
Previous filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PREVOZNIK MICHAEL E SVP & General Counsel 500 PLAZA DRIVE, SECAUCUS Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik 06 Mar 2026 0001222679

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Award +7,232 +19% $204.86* 44,789 04 Mar 2026 Direct F1
transaction DGX Common Stock Tax liability -3,354 -7.5% $204.86* 41,435 04 Mar 2026 Direct F2
transaction DGX Common Stock Sale $799,682 -3,878 -9.4% $206.21 37,557 05 Mar 2026 Direct F3
holding DGX Common Stock 5,737 04 Mar 2026 401(k)/SDCP F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
F2 Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.
F3 This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
F4 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.